Seres Therapeutics, Inc. (MCRB) insider trading

By person

22 insiders · 112 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Nutritional Health LTP Fund General Partner LLC entity

10% owner

$27.53M (2)

—

+$27.53M

6,201,513

$28.22M

—

Noubar Afeyan

Director

$20.00M (2)

—

+$20.00M

2,750,135

$12.51M

—

Matthew R Henn

See Remarks

—

$2.53M (16) scheduled

−$2.53M

7,995

$36.38K

—

Roger Pomerantz

Director

—

$2.06M (16) scheduled

−$2.06M

213,976

$973.59K

+16.5%

John G. Aunins

Chief Technology Officer & EVP

—

$1.00M (11)

−$1.00M

105,250

$478.89K

−45.2%

Eric D. Shaff

Director

—

$116.26K (15) scheduled

−$116.26K

12,499

$56.87K

—

Thomas DesRosier

See Remarks

—

$92.85K (15) scheduled

−$92.85K

8,117

$36.93K

—

David S. Ege

See Remarks

—

$89.14K (6)

−$89.14K

77,575

$352.97K

—

Teresa L. Young

See Remarks

—

$60.64K (12) scheduled

−$60.64K

8,557

$38.93K

—

Michele Trucksis

See Remarks

—

$28.73K (1) scheduled

−$28.73K

4,893

$22.26K

—

Moltke Lisa von

See Remarks

—

$19.26K (7) scheduled

−$19.26K

39,875

$181.43K

—

David N Cook

See Remarks

—

$19.15K (1) scheduled

−$19.15K

147,435

$670.83K

+7.9%

Marcus Chapman

See Remarks

—

$13.30K (1)

−$13.30K

8,600

$39.13K

—

David Arkowitz

Chief Financial Officer

—

$9.74K (2) scheduled

−$9.74K

182,442

$830.11K

+1,290%

Paula Cloghessy

See Remarks

—

$3.92K (1) scheduled

−$3.92K

45,684

$207.86K

+515.4%

Kelly Brady

See Remarks

—

$735.47 (2)

−$735.47

8,679

$39.49K

+2.8%

Flagship Ventures Fund IV General Partner LLC entity

10% owner

—

376,018

$1.71M

−95.5%

Richard N Kender

See Remarks

—

63,492

$288.89K

—

Paul Biondi

Director

—

47,619

$216.67K

—

Willard H Dere

Director

—

31,746

$144.44K

—

Meryl Zausner

Director

—

31,746

$144.44K

—

Stephen Berenson

Director

—

3,589

$16.33K

—

No percentages here. This company's share count has moved by a factor of 19.9 over the window, from 8,754,570 to 174,358,753 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Seres Therapeutics, Inc.

What the insiders did Net buying

By person